메뉴 건너뛰기




Volumn 15, Issue 8, 2001, Pages 1176-1184

A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF

Author keywords

Acute promyelocytic leukemia (APL); Apoptosis; Arsenic trioxide; Differentiation; GM CSF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ARSENIC TRIOXIDE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN TYROSINE KINASE; RECEPTOR SUBTYPE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR;

EID: 17944372810     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402162     Document Type: Article
Times cited : (37)

References (44)
  • 11
    • 0027448677 scopus 로고
    • Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications
    • (1993) Blood , vol.82 , pp. 1941-1953
    • Warrell R.P., Jr.1
  • 24
    • 0028321895 scopus 로고
    • Effects of arsenic on DNA damage and repair in human fetal lung fibloblasts
    • (1994) Mutat Res , vol.315 , pp. 11-15
    • Dong, J.T.1    Luo, X.M.2
  • 30
    • 0030953788 scopus 로고    scopus 로고
    • The kinase domain of Jak2 mediates induction of Bcl-2 and delays cell death in hematopoietic cellc
    • (1997) J Biol Chem , vol.272 , pp. 12350-12358
    • Sakai, I.1    Kraft, A.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.